Vimta Labs Limited (BOM: 524394)

Market Cap	16.70B
Revenue (ttm)	3.38B
Net Income (ttm)	500.13M
Shares Out	22.17M
EPS (ttm)	22.24
PE Ratio	34.35
Forward PE	n/a
Dividend	2.00 (0.27%)
Ex-Dividend Date	Jul 11, 2024

Volume	11,316
Open	756.95
Previous Close	761.45
Day's Range	741.25 - 770.00
52-Week Range	390.60 - 804.85
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 6, 2024

About Vimta Labs

Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, central lab, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to supp...

• Industry: Commercial Physical and Biological Research
• Founded: 1984
• Employees: 1,428
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524394

Financial Performance

In 2023, Vimta Labs's revenue was 3.19 billion, an increase of 0.08% compared to the previous year's 3.19 billion. Earnings were 410.09 million, a decrease of -14.87%.